investment opportunity: unique yellow laser technology for medical applications
DESCRIPTION
Presentation held by Thomas Lund, CEO of Advalight, at the Nordic Seed Capital Summit 2011 in Stockholm on 19 May 2011.TRANSCRIPT
www.advalight.com
Investment opportunity:
Unique yellow laser technology for medical applications
Stockholm, Sweden, May 19, 2011
By Thomas Lund, CEO
PERSPECTIVE
Niels Finsen, MD (1860-1904) Nobel Prize in Physiology or Medicine 1903
”treatment of skin diseases using concentrated sun light”
Source: http://nobelprize.org/nobel_prizes/lists/year/?year=1903
ADVALIGHT
Morten Thorhauge, Ph.D. Danish Optical Society Award 2010
”Yellow laser technology for medical applications”
Photos cou
rtesy of Ellipse
TODAY -‐ DERMATOLOGY
PROTOTYPE
MARKET IMPERFECTION
KEY OPINION LEADERS
END-‐CUSTOMER VALUE & COMPETING TECHNOLOGIES
Competitive position in the vascular area
Clin
ical eff
icacy
Cost efficacy d
Low High
Hig
h
Low
Green solid-state
Advalight solid-state Dye
IPL
THE NUMBERS
US$ 12m revenue
Match
2014 exit
US$ 750m market 15-20% CAGR
US$ 3m investment
PATENTS
WO/2008/006371 EP 09 17 3000
PA 2010 00304 DE 19794175